Literature DB >> 20494920

Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats.

Noreen F Rossi1, Maria Maliszewska-Scislo, Haiping Chen, Stephen M Black, Shruti Sharma, Ruslan Ravikov, Robert A Augustyniak.   

Abstract

The renin-angiotensin system is activated in the early phase of two-kidney, one-clip (2K-1C) hypertension. The paraventricular nucleus (PVN) integrates inputs regulating sympathetic outflow. The PVN receives inputs from plasma angiotensin II via projections from circumventricular organs and from renal afferent nerves transmitted via the nucleus tractus solitarii. Nitric oxide within the PVN may exert a sympathoinhibitory effect. These studies tested whether decreasing endogenous nitric oxide by introducing dominant negative (DN) constructs for neuronal nitric oxide synthase (nNOS) into PVN chronically augments hypertension and/or modulates baroreflex function. Male 6-week-old Sprague-Dawley rats underwent sham surgery or right renal artery clipping and placement of radiotelemetry transmitters. One week later, the PVN was injected bilaterally with 250 nl artificial cerebrospinal fluid containing 250 ng microl(-1) of RSV beta-galactosidase (beta-Gal), cytomegalovirus (CMV) wild-type (WT nNOS), or respiratory syncytial virus (RSV) haeme domain or RSV haemeRedF (DN nNOS). Haemodynamics were monitored for 5 weeks. Then left renal nerve electrodes were placed, and 2 days later the rats underwent baroreflex testing in the conscious state. The rise in mean arterial pressure (MAP) was significantly potentiated in the DN nNOS 2K-1C group beyond 15 days after PVN injection. By day 35, MAP in the 2K-1C groups was 152 +/- 6.3 (beta-Gal), 155.1 +/- 6.6 (WT nNOS) and 179 +/- 5.4 mmHg (DN nNOS; P < 0.01 versus all other groups). Sham-clipped rats remained normotensive. All groups displayed progressive bradycardia over time that was attenuated in the DN nNOS 2K-1C group. Baroreflex curves shifted to higher pressures, and baroreflex sensitivity of heart rate was diminished to a similar extent in all groups of 2K-1C rats. The baroreflex response of renal sympathetic nerve activity was preserved. The PVN tissue from DN nNOS rats had decreased dimerization of nNOS and generation of total nitric oxide. These findings indicate that chronic interference of nNOS dimerization required for generation of nitric oxide within the PVN potentiates the increase of blood pressure by modulating the sympathoexcitation that accompanies renovascular hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494920      PMCID: PMC2905784          DOI: 10.1113/expphysiol.2009.051789

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  50 in total

1.  Neurons in the lamina terminalis which project polysynaptically to the kidney express angiotensin AT1A receptor.

Authors:  M E Giles; D J Sly; M J McKinley; B J Oldfield
Journal:  Brain Res       Date:  2001-04-13       Impact factor: 3.252

2.  AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus.

Authors:  T Tagawa; R A Dampney
Journal:  Hypertension       Date:  1999-12       Impact factor: 10.190

3.  Time course of gene expression after plasmid DNA gene transfer to the liver.

Authors:  H Herweijer; G Zhang; V M Subbotin; V Budker; P Williams; J A Wolff
Journal:  J Gene Med       Date:  2001 May-Jun       Impact factor: 4.565

4.  Renal and cardiac sympathetic baroreflexes in hypertensive rabbits.

Authors:  G A Head; S L Burke
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

5.  Daily exercise normalizes the number of diaphorase (NOS) positive neurons in the hypothalamus of hypertensive rats.

Authors:  Stephen E DiCarlo; H Zheng; Heidi L Collins; David W Rodenbaugh; Kaushik P Patel
Journal:  Brain Res       Date:  2002-11-15       Impact factor: 3.252

6.  Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats.

Authors:  Yi-Fan Li; Shyamal K Roy; Keith M Channon; Irving H Zucker; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

7.  Use of chimeric forms of neuronal nitric-oxide synthase as dominant negative mutants.

Authors:  Y T Phung; S M Black
Journal:  IUBMB Life       Date:  1999-09       Impact factor: 3.885

8.  Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA.

Authors:  Y Li; W Zhang; J E Stern
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  [The expression of neuronal nitric oxide synthase in caudal medulla of two-kidney one clip Goldblatt hypertension rat].

Authors:  Jing Wang; Zhi-Jiang Chen; Can-Qiao Luo; Jing-Yun Pan
Journal:  Sheng Li Xue Bao       Date:  2002-04-25

Review 10.  Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone.

Authors:  R A L Dampney; J Horiuchi; T Tagawa; M A P Fontes; P D Potts; J W Polson
Journal:  Acta Physiol Scand       Date:  2003-03
View more
  22 in total

1.  Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension.

Authors:  Carrie A Northcott; Scott Billecke; Teresa Craig; Carmen Hinojosa-Laborde; Kaushik P Patel; Alex F Chen; Louis G D'Alecy; Joseph R Haywood
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

2.  Attenuated muscle metaboreflex-induced increases in cardiac function in hypertension.

Authors:  Javier A Sala-Mercado; Marty D Spranger; Rania Abu-Hamdah; Jasdeep Kaur; Matthew Coutsos; Douglas Stayer; Robert A Augustyniak; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

3.  Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.

Authors:  Renata V Tiradentes; Cintia H Santuzzi; Erick Rg Claudio; Vinicius Mengal; Nyam F Silva; Henrique A F Neto; Nazaré S Bissoli; Glaucia R Abreu; Sonia A Gouvea
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

4.  Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN.

Authors:  Neeru M Sharma; Tamra L Llewellyn; Hong Zheng; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-05       Impact factor: 4.733

Review 5.  Neurogenic hypertension: revelations from genome-wide gene expression profiling.

Authors:  Francine Z Marques; Brian J Morris
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

6.  Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Sanjiv Kumar; Shruti Sharma; Saurabh Aggarwal; Frank Schneider; Danny Jonigk; Stephen M Black; Stevan P Tofovic
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

Review 7.  The role of CNS in salt-sensitive hypertension.

Authors:  Megumi Fujita; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

8.  Paraventricular nucleus control of blood pressure in two-kidney, one-clip rats: effects of exercise training and resting blood pressure.

Authors:  Noreen F Rossi; Haiping Chen; Maria Maliszewska-Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-10-02       Impact factor: 3.619

9.  Hemodynamic and neural responses to renal denervation of the nerve to the clipped kidney by cryoablation in two-kidney, one-clip hypertensive rats.

Authors:  Noreen F Rossi; Russell Pajewski; Haiping Chen; Peter J Littrup; Maria Maliszewska-Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-18       Impact factor: 3.619

Review 10.  Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states.

Authors:  Ahmmed Ally; Isabella Powell; Minori M Ally; Kevin Chaitoff; Surya M Nauli
Journal:  Nitric Oxide       Date:  2020-06-23       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.